Ks logo

ニュース&インサイト

Subscribe
Icon search Icon close

  • People
  • OfficesIcon submenu
    • Icon submenu back back
    • Offices
    • North AmericaIcon submenu
      • Icon submenu back back
      • North America
      • Atlanta
      • Austin
      • Charlotte
      • Chicago
      • Houston
      • Los Angeles
      • New York
      • Northern Virginia
      • San Francisco
      • Silicon Valley
      • Washington, D.C.
    • Europe & Middle EastIcon submenu
      • Icon submenu back back
      • Europe & Middle East
      • Abu Dhabi
      • Brussels
      • Dubai
      • Frankfurt
      • Geneva
      • London
      • Moscow
      • Paris
      • Riyadh
    • AsiaIcon submenu
      • Icon submenu back back
      • Asia
      • Singapore
      • Tokyo
  • CapabilitiesIcon submenu
    • Icon submenu back back
    • Capabilities
    • Corporate, Finance and InvestmentsIcon submenu
      • Icon submenu back back
      • Corporate, Finance and Investments
      • Overview
      • Activist Defense
      • Capital Markets
      • Construction and Procurement
      • Corporate Governance
      • Emerging Companies and Venture Capital
      • Employee Benefits and Executive Compensation
      • Energy and Infrastructure Projects
      • Financial Restructuring
      • Global Human Capital and Compliance
      • Investment Funds and Asset Management
      • Leveraged Finance
      • Mergers and Acquisitions
      • Middle East and Islamic Finance and Investment
      • Private Credit & Special Situations Investing
      • Private Equity
      • Real Estate
      • Securitization
      • Tax
      • Technology Transactions
    • Government MattersIcon submenu
      • Icon submenu back back
      • Government Matters
      • Overview
      • Antitrust
      • Data, Privacy and Security
      • Environmental, Health and Safety
      • FDA and Life Sciences
      • Government Advocacy and Public Policy
      • Government Contracts
      • Healthcare
      • International Trade
      • National Security and Corporate Espionage
      • Securities Enforcement and Regulation
      • Special Matters and Government Investigations
    • Trial and Global DisputesIcon submenu
      • Icon submenu back back
      • Trial and Global Disputes
      • Overview
      • Appellate, Constitutional and Administrative Law
      • Bankruptcy and Insolvency Litigation
      • Class Action Defense
      • Commercial Litigation
      • Construction and Engineering Disputes
      • Corporate and Securities Litigation
      • E-Discovery
      • Insurance Coverage and Recovery
      • Intellectual Property, Patent, Trademark and Copyright Litigation
      • International Arbitration and Litigation
      • Labor and Employment
      • Product Liability
      • Professional Liability
      • Toxic & Environmental Torts
    • Industries / IssuesIcon submenu
      • Icon submenu back back
      • Industries / Issues
      • Industries
      • Automotive, Transportation and Mobility
      • Energy
      • Financial Services
      • Food and Beverage
      • Franchise and Hospitality
      • Higher Education
      • Life Sciences and Healthcare
      • Technology
      • Issues
      • #MeToo
      • COVID-19 Vaccine Rollout
      • Coronavirus
      • Crisis Practice
      • Focus on Women's Health
      • The New Administration: Enforcement and Legislative Impact
  • CareersIcon submenu
    • Icon submenu back back
    • Careers
    • LawyersIcon submenu
      • Icon submenu back back
      • Lawyers
      • Experienced Lawyers
    • StudentsIcon submenu
      • Icon submenu back back
      • Students
      • Law Students
      • UK Graduate Recruitment
    • Judicial ClerksIcon submenu
      • Icon submenu back back
      • Judicial Clerks
      • Judicial Clerks
    • Other ProfessionalsIcon submenu
      • Icon submenu back back
      • Other Professionals
      • Other Professionals
  • News & InsightsIcon submenu
    • Icon submenu back back
    • News & Insights
    • NewsIcon submenu
      • Icon submenu back back
      • News
      • Cases & Deals
      • In the News
      • Press Releases
      • Recognitions
    • EventsIcon submenu
      • Icon submenu back back
      • Events
      • Conferences
      • Speaking Engagements
      • Webinars
    • InsightsIcon submenu
      • Icon submenu back back
      • Insights
      • Newsletters
      • Client Alerts
      • Thought Leadership
      • Articles
      • Feature
      • BLOGS
      • COVID-19 Vaccine Updates
      • China Subsidy Exchange
      • Energy Law Exchange
  • AboutIcon submenu
    • Icon submenu back back
    • About
    • Our FirmIcon submenu
      • Icon submenu back back
      • Our Firm
      • History
      • Our Values
    • DiversityIcon submenu
      • Icon submenu back back
      • Diversity
      • Overview
      • Women’s Initiatives
      • Racial Diversity
      • LBGTQ+ Affinity
    • CitizenshipIcon submenu
      • Icon submenu back back
      • Citizenship
      • Overview
      • Pro Bono
      • Community Focus
  • Languages

ニュース&インサイト

  • NewsIcon submenu
    • Icon submenu back back
    • News
    • Cases & Deals
    • In the News
    • Press Releases
    • Recognitions
  • EventsIcon submenu
    • Icon submenu back back
    • Events
    • Conferences
    • Speaking Engagements
    • Webinars
  • InsightsIcon submenu
    • Icon submenu back back
    • Insights
    • Newsletters
    • Client Alerts
    • Thought Leadership
    • Articles
    • Feature
    • BLOGS
    • COVID-19 Vaccine Updates
    • China Subsidy Exchange
    • Energy Law Exchange
Calendar view

Event 210 results

Webinar

3月 17, 2021
Issues Facing California Healthcare Providers: Class Action Litigation in the Wake of the Covid-19 Pandemic and Developing Legislation

Webinar

3月 16, 2021
The New Intensified Scrutiny and Enforcement of FDA-Regulated Clinical Trials

Webinar

3月 4, 2021
Talk im Turm – AI & Life Sciences: Where do we stand in the EU and what to expect in 2021?

Webinar

2月 25, 2021
International Arbitration of Technology Disputes: Perspectives from Silicon Valley and Singapore

Webinar

2月 24, 2021
The Biden Administration’s U.S.-Asia Trade Priorities: What Businesses and Investors Need to Know

Webinar

2月 23, 2021
FDA Inspections in 2021 for Drug and Device Manufacturers

Webinar

2月 23, 2021
Key Food and Beverage Issues: Challenges and Opportunities in 2021

Webinar

2月 16, 2021
Budget Reconciliation—A Conversation with Peter Robinson, Former Senate Senior Assistant Parliamentarian

Webinar

2月 10, 2021
Talk im Turm: AML - New requirements (also for investment fund managers) according to the BaFin draft guidelines on AML for credit institutions and the first draft of the Act on the implementation of the European Financial Information Directive

Webinar

2月 8, 2021
Egishe Dzhazoyan to Speak on American University of Armenia Virtual Panel

Webinar

2月 4, 2021
A Sea Change: Environmental Enforcement

Webinar

1月 28, 2021
Talk im Turm – Amendments to the Law Against Unfair Competition (UWG) 2020: Change in Tactics is Necessary!

© 2021 King & Spalding LLP
  • Contact Us
  • Disclaimer
  • Privacy Notice
  • Cookie Policy
  • Copyright Notice
  • Regulatory Notices
  • Client Extranet
  • K&S Alumni Group